EQRx

Acquired

Remaking Medicine™

Cambridge, United States · Founded 2019 · $700.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Website
eqrx.com
Total Funding
$700.0M
Last Round
$500.0M Series BJan 2021
Rounds
2
Acquisition Date
Aug 2023

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

EQRx was a biopharmaceutical company founded in 2019 committed to developing innovative, patent-protected medicines and delivering them at dramatically lower prices than traditional pharmaceutical companies. The company built a pipeline of 10+ programs including Phase 3 oncology assets for non-small cell lung cancer, raised over $750 million in funding, and was acquired by Revolution Medicines in November 2023.

Summary

EQRx is a Healthcare company based in Cambridge, United States, founded in 2019. It has raised $700.0M in total across 2 rounds, most recently a $500.0M Series B round in Jan 2021. Investors include Andreessen Horowitz, GV and ARCH Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionAug 2023

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EQRx on Indexed.vc
<a href="https://indexed.vc/companies/eqrx"><img src="https://indexed.vc/api/badge/company/eqrx" alt="EQRx on Indexed.vc" width="260" height="76" /></a>